{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T05:40:10Z","timestamp":1751521210323,"version":"3.41.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The aim of this study was to describe the characteristics and outcomes of acute myocarditis (AM) patients while seeking accessible and valid early predictors for the development of dilated cardiomyopathy (DCM).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective evaluation of 136 consecutive AM patients admitted to our hospital. The patients were categorized into two groups according to their left ventricular ejection fraction (LVEF) at presentation: those with an impaired LVEF of \u226455% and those with a normal LVEF of &amp;gt;55%. Multivariate logistic regression analyses were conducted to identify early predictors of DCM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The median age of the study participants was 10.35 years (5.60\u201314.70), and most of the participants (66.91%) were males. Thirty-eight (27.94%) patients had an LVEF of \u226455%. Compared with those with an LVEF &amp;gt;55%, patients with an LVEF \u226455% presented significantly elevated levels of cardiac troponin I (cTnI) and N-terminal pro-B-type natriuretic peptide (NT-proBNP), as well as more pronounced clinical manifestations, including a greater prevalence of fulminant myocarditis, New York Heart Association (NYHA) class II-IV, abnormal electrocardiogram results, and enlargement of the left ventricle on echocardiography. Univariate analysis revealed that patients with an LVEF of \u226455% had an increased risk of poor outcomes and DCM development. These patients faced the greatest likelihood of death and heart transplantation within the first year following discharge. During short-term follow-up, 15.44% of the children with AM progressed to DCM. According to the multivariable analysis, a higher baseline LV end-diastolic diameter z score (LVEDD z-score) independently predicted this progression (odds ratio [OR], 2.685; 95% confidence interval [CI], 1.232\u20135.851; <jats:italic>P<\/jats:italic>\u2009=\u20090.013).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Patients with AM and LVEF \u226455% had a more severe clinical course, higher rates of poor outcomes, and increased risk of DCM progression. Moreover, this subgroup was at the greatest risk for death and heart transplant within the first year post-discharge. During short-term follow-up, 15.44% of the children diagnosed with AM progressed to DCM, with a higher baseline LVEDD z-score identified as a potential early predictor for this progression.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2025.1616751","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T05:26:23Z","timestamp":1751520383000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical presentation and early predictors of progression to dilated cardiomyopathy in children with acute myocarditis"],"prefix":"10.3389","volume":"13","author":[{"given":"Liu","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusheng","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1161\/circulationaha.118.035319","article-title":"Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis","volume":"138","author":"Ammirati","year":"2018","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e031454","DOI":"10.1161\/jaha.123.031454","article-title":"Diagnostic approach for suspected acute myocarditis: considerations for standardization and broadening clinical spectrum","volume":"12","author":"Martens","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1001\/jama.2023.3371","article-title":"Diagnosis and treatment of acute myocarditis: a review","volume":"329","author":"Ammirati","year":"2023","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1253\/circj.CJ-16-0234","article-title":"Clinical features of acute and fulminant myocarditis in children\u20132nd nationwide survey by Japanese society of pediatric cardiology and cardiac surgery","volume":"80","author":"Matsuura","year":"2016","journal-title":"Circ J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e007405","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405","article-title":"Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document","volume":"13","author":"Ammirati","year":"2020","journal-title":"Circ Heart Fail"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/pin.12868","article-title":"Inflammation in myocardial disease: from myocarditis to dilated cardiomyopathy","volume":"70","author":"Imanaka-Yoshida","year":"2019","journal-title":"Pathol Int"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1136\/heartjnl-2021-319027","article-title":"Diagnosis, risk stratification and management of myocarditis","volume":"108","author":"M\u00fcller","year":"2022","journal-title":"Heart"},{"key":"B8","doi-asserted-by":"publisher","first-page":"548","DOI":"10.12998\/wjcc.v7.i5.548","article-title":"Clinical presentation and early predictors for poor outcomes in pediatric myocarditis: a retrospective study","volume":"7","author":"Rodriguez-Gonzalez","year":"2019","journal-title":"World J Clin Cases"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00246-017-1638-1","article-title":"Characteristics of clinically diagnosed pediatric myocarditis in a contemporary multi-center cohort","volume":"38","author":"Butts","year":"2017","journal-title":"Pediatr Cardiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.amjmed.2019.10.015","article-title":"Epidemiology characteristics and outcome of patients with clinically diagnosed acute myocarditis","volume":"133","author":"Younis","year":"2020","journal-title":"Am J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3760\/cma.j.issn.0578-1310.2019.02.004","article-title":"Recommendations for the diagnosis of myocarditis in children (2018 edition)","volume":"57","year":"2018","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIR.0000000000000682","article-title":"Cardiomyopathy in children: classification and diagnosis: a scientific statement from the American heart association","volume":"140","author":"Lipshultz","year":"2019","journal-title":"Circulation"},{"key":"B13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41392-020-00360-y","article-title":"Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes","volume":"5","author":"Hang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","article-title":"Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations","volume":"72","author":"Ferreira","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00431-023-05362-w","article-title":"The diagnosis and treatment of pediatric clinical myocarditis in China: a multicenter retrospective study","volume":"183","author":"Li","year":"2023","journal-title":"Eur J Pediatr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e005306","DOI":"10.1161\/jaha.116.005306","article-title":"Occurrence and features of childhood myocarditis: a nationwide study in Finland","volume":"6","author":"Arola","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"B17","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s00380-012-0296-8","article-title":"Clinical characteristics and long-term outcome of acute myocarditis in children","volume":"28","author":"Abe","year":"2013","journal-title":"Heart Vessels"},{"key":"B18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1017\/s1047951116000706","article-title":"Left ventricular end-diastolic dimension as a predictive factor of outcomes in children with acute myocarditis","volume":"27","author":"Kim","year":"2016","journal-title":"Cardiol Young"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1161\/circulationaha.113.002767","article-title":"Long-term outcomes of dilated cardiomyopathy diagnosed during childhood","volume":"128","author":"Alexander","year":"2013","journal-title":"Circulation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1161\/cir.0000000000001001","article-title":"Diagnosis and management of myocarditis in children","volume":"144","author":"Law","year":"2021","journal-title":"Circulation"},{"key":"B21","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.repce.2020.10.020","article-title":"Could the unfortunate outcome of pediatric acute myocarditis be predicted? Factors contributing to a poor outcome in myocarditis","volume":"40","author":"Krasic","year":"2021","journal-title":"Rev Port Cardiol (Engl Ed)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e0214616","DOI":"10.1371\/journal.pone.0214616","article-title":"Persistent left ventricular dysfunction after acute lymphocytic myocarditis: frequency and predictors","volume":"14","author":"Merlo","year":"2019","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1161\/circulationaha.113.003092","article-title":"Long-term evolution and prognostic stratification of biopsy-proven active myocarditis","volume":"128","author":"Anzini","year":"2013","journal-title":"Circulation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s11886-018-1054-z","article-title":"Acute and fulminant myocarditis: a pragmatic clinical approach to diagnosis and treatment","volume":"20","author":"Ammirati","year":"2018","journal-title":"Curr Cardiol Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jacc.2019.04.063","article-title":"Fulminant versus acute nonfulminant myocarditis in patients with left ventricular systolic dysfunction","volume":"74","author":"Ammirati","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1161\/circulationaha.121.058869","article-title":"Features and outcomes of histologically proven myocarditis with fulminant presentation","volume":"146","author":"Kanaoka","year":"2022","journal-title":"Circulation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ejphar.2009.12.019","article-title":"Left ventricular enlargement in coxsackievirus-B3 induced chronic myocarditis \u2014 ongoing inflammation and an imbalance of the matrix degrading system","volume":"630","author":"Rutschow","year":"2010","journal-title":"Eur J Pharmacol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1616751\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T05:26:25Z","timestamp":1751520385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1616751\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":27,"alternative-id":["10.3389\/fped.2025.1616751"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1616751","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]}}}